Taken together, our data additively show that PDE5A alterations begin at a very early stage in cardiac hypertrophy leading to heart failure, and that the reported increase in PDE5 activity occurs before the loss of its intracellular localization to Z-bands and alteration of NOS3 expression. Here, NOS3 is linked to cardiac hypertrophy.